S Duan, Y Hu, Y Zhao, K Tang, Z Zhang, Z Liu… - RSC …, 2023 - pubs.rsc.org
Cancer has emerged as a pressing global public health issue, and improving the effectiveness of cancer treatment remains one of the foremost challenges of modern …
Oxaliplatin was the third Pt-based anticancer drug to be clinically used worldwide. It exhibits a broad spectrum of anticancer activity and was the first to be approved for the treatment of …
Microbial exopolysaccharides (EPSs), eg, xanthan, dextran, gellan, curdlan, etc., have significant applications in several industries (pharma, food, textiles, petroleum, etc.) due to …
T Andreani, R Cheng, K Elbadri, C Ferro… - Drug Delivery and …, 2024 - Springer
Several efforts have been extensively accomplished for the amelioration of the cancer treatments using different types of new drugs and less invasives therapies in comparison …
K Kitsios, S Sharifi, M Mahmoudi - ACS Pharmacology & …, 2023 - ACS Publications
Breast cancer is one of the most common cancers in women worldwide, yet conventional treatments have several shortcomings, including low specificity, systemic toxicity, and drug …
Cancer is well recognized as a leading cause of mortality. Although surgery tends to be the primary treatment option for many solid cancers, cancer surgery is still a risk factor for …
Nano-drug delivery is a promising tactic to enhance the activity and minimize the cytotoxicity of antimicrobial drugs. In the current study, chitosan nanoparticles (CSNPs) were used as a …
Leukemia is a group of malignant disorders which affect the blood and blood-forming tissues in the bone marrow, lymphatic system, and spleen. Many types of leukemia exist; thus, their …
M Abbasi, DA Boka, H DeLoit - Pharmaceutics, 2024 - mdpi.com
Drug delivery systems (DDS) have improved therapeutic agent administration by enhancing efficacy and patient compliance while minimizing side effects. They enable targeted delivery …